Latest Trials

E7080-M091-511 Tittle

E7080-M091-511 Tittle "A Prospective, Multicentre, Post-Marketing Phase IV Study to Assess the safety and Efficacy of Lenvatinib as First-Line Treatment in Patients with Unresectable Hepatocellular Carcinoma (HCC)".